Physician profile
Cody L Fox
NPI 1366768939
$2,059.02
in general payments reported to CMS, 2019-2025
17 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.59 · 2020: $100 · 2021: $187 · 2022: $265 · 2023: $558 · 2024: $369 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396 · Education: $39.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.85 |
| Education | $39.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,098.51 | 2022-2025 | |
| Stryker Corporation | $242.52 | 2020-2025 | Ortholoc 2 Lapifuse, Inbone, Axs Infinity Ls |
| Smith+Nephew, INC. | $154.99 | 2021-2024 | Collagenase Santyl |
| Organogenesis INC. | $80.57 | 2021-2025 | Puraply, Cygnus Dual |
| Becton, Dickinson and Company | $77.19 | 2025 | Arista |
| Elite Orthopedics, LLC | $58.09 | 2020-2025 | |
| Abbvie INC. | $51.35 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $46.98 | 2025 | |
| Paratek Pharmaceuticals, INC. | $43.08 | 2019-2023 | Nuzyra |
| Depuy Synthes Sales INC. | $41.65 | 2024 | Dynaforce, N/A, Hammerlock |
| Pacira Therapeutics, INC. | $38.51 | 2020 | |
| Convatec INC. | $33.72 | 2019-2023 | |
| Integra Lifesciences Corporation | $30.02 | 2019 | |
| Fidia Pharma USA INC. | $17.26 | 2024 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $16.26 | 2023 | Seglentis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $15.98 | 2023 | Hammertube |
| Bioventus LLC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.